- Home
- TLNC vs PEPG Comparison
TLNC vs PEPG Comparison
Compare TLNC & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLNC
- PEPG
- Stock Information
- Founded
- TLNC 2025
- PEPG 2018
- Country
- TLNC United States
- PEPG United States
- Employees
- TLNC N/A
- PEPG N/A
- Industry
- TLNC
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- TLNC
- PEPG Health Care
- Exchange
- TLNC Nasdaq
- PEPG Nasdaq
- Market Cap
- TLNC 338.8M
- PEPG 317.6M
- IPO Year
- TLNC 2025
- PEPG 2022
- Fundamental
- Price
- TLNC $10.14
- PEPG $5.99
- Analyst Decision
- TLNC
- PEPG Strong Buy
- Analyst Count
- TLNC 0
- PEPG 6
- Target Price
- TLNC N/A
- PEPG $9.50
- AVG Volume (30 Days)
- TLNC 969.0
- PEPG 756.9K
- Earning Date
- TLNC 01-01-0001
- PEPG 11-12-2025
- Dividend Yield
- TLNC N/A
- PEPG N/A
- EPS Growth
- TLNC N/A
- PEPG N/A
- EPS
- TLNC N/A
- PEPG N/A
- Revenue
- TLNC N/A
- PEPG N/A
- Revenue This Year
- TLNC N/A
- PEPG N/A
- Revenue Next Year
- TLNC N/A
- PEPG N/A
- P/E Ratio
- TLNC N/A
- PEPG N/A
- Revenue Growth
- TLNC N/A
- PEPG N/A
- 52 Week Low
- TLNC $9.98
- PEPG $0.88
- 52 Week High
- TLNC $11.04
- PEPG $6.85
- Technical
- Relative Strength Index (RSI)
- TLNC N/A
- PEPG 64.36
- Support Level
- TLNC N/A
- PEPG $5.41
- Resistance Level
- TLNC N/A
- PEPG $6.14
- Average True Range (ATR)
- TLNC 0.00
- PEPG 0.56
- MACD
- TLNC 0.00
- PEPG 0.09
- Stochastic Oscillator
- TLNC 0.00
- PEPG 97.61
About TLNC Talon Capital Corp. Class A Ordinary Shares
Talon Capital Corp is a newly organized blank check company.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.